Total planned funding: $1,145,076,931
Allocations
Countries/Regions
| Kenya | $134,449,097 |
| Tanzania | $118,346,829 |
| South Africa | $116,876,224 |
| Nigeria | $112,661,840 |
| Mozambique | $95,176,001 |
| Uganda | $91,428,748 |
| Zambia | $82,096,390 |
| Ethiopia | $52,283,657 |
| Zimbabwe | $31,070,881 |
| Côte d'Ivoire | $30,381,740 |
| Haiti | $26,068,709 |
| Rwanda | $25,457,869 |
| Vietnam | $22,670,695 |
| Namibia | $22,627,885 |
| Malawi | $22,397,368 |
| Botswana | $20,006,118 |
| Democratic Republic of the Congo | $16,530,737 |
| India | $14,602,411 |
| Eswatini | $11,466,084 |
| Cambodia | $10,202,985 |
| Cameroon | $10,105,468 |
| Lesotho | $8,605,531 |
| Indonesia | $7,723,434 |
| Guyana | $7,242,874 |
| Ukraine | $6,600,677 |
| South Sudan | $6,315,527 |
| Central Asia Region | $5,963,071 |
| Angola | $5,658,194 |
| Russia | $5,218,000 |
| Dominican Republic | $4,725,303 |
| Ghana | $3,910,282 |
| Central America Region | $3,711,194 |
| Asia Regional Program | $3,090,257 |
| China | $3,073,750 |
| Thailand | $2,109,956 |
| Papua New Guinea | $1,836,550 |
| Burundi | $1,581,725 |
| Caribbean Region | $802,870 |
Organizational Types
| NGO | $415,100,925 |
| Unknown | $181,567,000 |
| Private Contractor | $159,412,565 |
| University | $141,482,086 |
| Host Country Government Agency | $91,276,231 |
| FBO | $51,362,757 |
| Own Agency | $44,519,822 |
| Implementing Agency | $30,596,860 |
| Other USG Agency | $12,347,775 |
| Parastatal | $9,040,814 |
| Multi-lateral Agency | $8,370,096 |
Program Areas
| Prevention | $1,145,076,931 |
Budget Codes
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $393,983,384 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $286,830,853 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $199,565,370 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $147,262,857 |
| HMBL: Biomedical Prevention: Blood Safety | $79,375,593 |
| HMIN: Biomedical Prevention: Injection Safety | $20,305,483 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $17,753,391 |